Retinal vessels modifications in acute and post-COVID-19

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2 primarily affecting the respiratory system which can damage vessels walls virtually in any body district. Changes affecting retinal vessels are a good marker for systemic vascular alterations. This study inves...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alessandro Invernizzi, Marco Schiuma, Salvatore Parrulli, Alessandro Torre, Federico Zicarelli, Valeria Colombo, Sara Marini, Elena Villella, Alice Bertoni, Spinello Antinori, Giuliano Rizzardini, Massimo Galli, Luca Meroni, Andrea Giacomelli, Giovanni Staurenghi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3c4ec8d0fd8544e99dbd01027a0ff4a2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3c4ec8d0fd8544e99dbd01027a0ff4a2
record_format dspace
spelling oai:doaj.org-article:3c4ec8d0fd8544e99dbd01027a0ff4a22021-12-02T19:17:04ZRetinal vessels modifications in acute and post-COVID-1910.1038/s41598-021-98873-12045-2322https://doaj.org/article/3c4ec8d0fd8544e99dbd01027a0ff4a22021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98873-1https://doaj.org/toc/2045-2322Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2 primarily affecting the respiratory system which can damage vessels walls virtually in any body district. Changes affecting retinal vessels are a good marker for systemic vascular alterations. This study investigated retinal vessels during the acute phase of COVID-19 and after patients recovery. Fifty-nine eyes from 32 COVID-19 patients and 80 eyes from 53 unexposed subjects were included. Mean arteries diameter (MAD) and mean veins diameter (MVD) were assessed through semi-automatic analysis on fundus color photos at baseline and 6 months later in patients and subjects unexposed to the virus. At baseline MAD and MVD were significantly higher in COVID-19 patients compared to unexposed subjects (p < 0.0001). Both MAD and MVD significantly decreased in COVID-19 patients at follow-up (from 97.5 ± 10.9 to 92.2 ± 11.4 µm, p < 0.0001 and from 133.1 ± 19.3 to 124.6 ± 16.1 µm, p < 0.0001, respectively). Despite this reduction vessels diameter remained significantly higher in severe COVID-19 patients compared to unexposed subjects. Transient retinal vessels dilation could serve a biomarker for systemic inflammation while long-lasting alterations seen in severe COVID-19 likely reflect irreversible structural damage to the vessels walls and should be further investigated for their possible effects on tissues perfusion and function.Alessandro InvernizziMarco SchiumaSalvatore ParrulliAlessandro TorreFederico ZicarelliValeria ColomboSara MariniElena VillellaAlice BertoniSpinello AntinoriGiuliano RizzardiniMassimo GalliLuca MeroniAndrea GiacomelliGiovanni StaurenghiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alessandro Invernizzi
Marco Schiuma
Salvatore Parrulli
Alessandro Torre
Federico Zicarelli
Valeria Colombo
Sara Marini
Elena Villella
Alice Bertoni
Spinello Antinori
Giuliano Rizzardini
Massimo Galli
Luca Meroni
Andrea Giacomelli
Giovanni Staurenghi
Retinal vessels modifications in acute and post-COVID-19
description Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2 primarily affecting the respiratory system which can damage vessels walls virtually in any body district. Changes affecting retinal vessels are a good marker for systemic vascular alterations. This study investigated retinal vessels during the acute phase of COVID-19 and after patients recovery. Fifty-nine eyes from 32 COVID-19 patients and 80 eyes from 53 unexposed subjects were included. Mean arteries diameter (MAD) and mean veins diameter (MVD) were assessed through semi-automatic analysis on fundus color photos at baseline and 6 months later in patients and subjects unexposed to the virus. At baseline MAD and MVD were significantly higher in COVID-19 patients compared to unexposed subjects (p < 0.0001). Both MAD and MVD significantly decreased in COVID-19 patients at follow-up (from 97.5 ± 10.9 to 92.2 ± 11.4 µm, p < 0.0001 and from 133.1 ± 19.3 to 124.6 ± 16.1 µm, p < 0.0001, respectively). Despite this reduction vessels diameter remained significantly higher in severe COVID-19 patients compared to unexposed subjects. Transient retinal vessels dilation could serve a biomarker for systemic inflammation while long-lasting alterations seen in severe COVID-19 likely reflect irreversible structural damage to the vessels walls and should be further investigated for their possible effects on tissues perfusion and function.
format article
author Alessandro Invernizzi
Marco Schiuma
Salvatore Parrulli
Alessandro Torre
Federico Zicarelli
Valeria Colombo
Sara Marini
Elena Villella
Alice Bertoni
Spinello Antinori
Giuliano Rizzardini
Massimo Galli
Luca Meroni
Andrea Giacomelli
Giovanni Staurenghi
author_facet Alessandro Invernizzi
Marco Schiuma
Salvatore Parrulli
Alessandro Torre
Federico Zicarelli
Valeria Colombo
Sara Marini
Elena Villella
Alice Bertoni
Spinello Antinori
Giuliano Rizzardini
Massimo Galli
Luca Meroni
Andrea Giacomelli
Giovanni Staurenghi
author_sort Alessandro Invernizzi
title Retinal vessels modifications in acute and post-COVID-19
title_short Retinal vessels modifications in acute and post-COVID-19
title_full Retinal vessels modifications in acute and post-COVID-19
title_fullStr Retinal vessels modifications in acute and post-COVID-19
title_full_unstemmed Retinal vessels modifications in acute and post-COVID-19
title_sort retinal vessels modifications in acute and post-covid-19
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3c4ec8d0fd8544e99dbd01027a0ff4a2
work_keys_str_mv AT alessandroinvernizzi retinalvesselsmodificationsinacuteandpostcovid19
AT marcoschiuma retinalvesselsmodificationsinacuteandpostcovid19
AT salvatoreparrulli retinalvesselsmodificationsinacuteandpostcovid19
AT alessandrotorre retinalvesselsmodificationsinacuteandpostcovid19
AT federicozicarelli retinalvesselsmodificationsinacuteandpostcovid19
AT valeriacolombo retinalvesselsmodificationsinacuteandpostcovid19
AT saramarini retinalvesselsmodificationsinacuteandpostcovid19
AT elenavillella retinalvesselsmodificationsinacuteandpostcovid19
AT alicebertoni retinalvesselsmodificationsinacuteandpostcovid19
AT spinelloantinori retinalvesselsmodificationsinacuteandpostcovid19
AT giulianorizzardini retinalvesselsmodificationsinacuteandpostcovid19
AT massimogalli retinalvesselsmodificationsinacuteandpostcovid19
AT lucameroni retinalvesselsmodificationsinacuteandpostcovid19
AT andreagiacomelli retinalvesselsmodificationsinacuteandpostcovid19
AT giovannistaurenghi retinalvesselsmodificationsinacuteandpostcovid19
_version_ 1718376906179477504